Category : Clinical Research, Pharma & Healthcare Financing

Clinical Research, Pharma & Healthcare Financing

Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay

Business Wire
by Business Wire0156
Invivoscribe is proud to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM), LLC has received approval from the New York State...
Clinical Research, Pharma & Healthcare Financing

Aurion Biotech Appoints Edward J. Holland, M.D., and Eris P. Jordan, O.D.

Business Wire
by Business Wire0171
Key leadership appointments to accelerate global clinical development of AURN001, a transformational cell therapy for corneal endothelial disease Aurion Biotech, a clinical-stage regenerative medicine company...
Clinical Research, Pharma & Healthcare Financing

Onward Therapeutics Announces IMPD Approval for OT-C001 Trial

PR Newswire
by PR Newswire0180
Onward Therapeutics SA, a biotechnology company dedicated to advancing innovative cancer immunotherapies, announced that its subsidiary, Emercell SAS, has received Investigational Medicinal Product Dossier (IMPD)...
Clinical Research, Pharma & Healthcare Financing

City of Hope to Present AI, Precision Medicine at AACR 2025

Business Wire
by Business Wire0241
More than 74 chaired, plenary and educational sessions, minisymposium, posters and more will report on new technologies and novel treatments related to breast, nasopharyngeal, colon...
Clinical Research, Pharma & Healthcare Financing

ENHERTU + Pertuzumab Shows PFS Gain in HER2+ Breast Cancer

Business Wire
by Business Wire0150
Positive topline results from a planned interim analysis of the DESTINY-Breast09 phase 3 trial showed ENHERTU® (trastuzumab deruxtecan) in combination with pertuzumab demonstrated a highly statistically significant and...
Clinical Research, Pharma & Healthcare Financing

HighField Files INDs for Two ADCplex™ Cancer Therapies

Business Wire
by Business Wire0249
The new technology behind HighField’s immunoliposomes may offer greater safety and efficacy than existing antibody drug conjugates (ADCs) HighField Biopharmaceuticals, a clinical stage company using lipid-based...
Clinical Research, Pharma & Healthcare Financing

Alis Biosciences Launches Fund to Unlock $30B in Trapped Capital

PR Newswire
by PR Newswire0231
Alis Biosciences (“Alis”), an investment fund focused on returning capital to investors that is currently trapped in listed, development-stage biotech companies, today formally launches. Founded by highly...